159 related articles for article (PubMed ID: 26579965)
1. Internal Auditory Canal Decompression for Hearing Maintenance in Neurofibromatosis Type 2 Patients.
Bernardeschi D; Peyre M; Collin M; Smail M; Sterkers O; Kalamarides M
Neurosurgery; 2016 Sep; 79(3):370-7. PubMed ID: 26579965
[TBL] [Abstract][Full Text] [Related]
2. Hearing Response Following Internal Auditory Canal Decompression in Neurofibromatosis Type 2.
Bonne NX; Risoud M; Hoa M; Lemesre PE; Aboukais R; Le Rhun E; Dubrulle F; Baroncini M; Lejeune JP; Vincent C
Neurosurgery; 2019 Sep; 85(3):E560-E567. PubMed ID: 30888036
[TBL] [Abstract][Full Text] [Related]
3. Middle fossa decompression for hearing preservation: a review of institutional results and indications.
Slattery WH; Hoa M; Bonne N; Friedman RA; Schwartz MS; Fisher LM; Brackmann DE
Otol Neurotol; 2011 Aug; 32(6):1017-24. PubMed ID: 21725256
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
[TBL] [Abstract][Full Text] [Related]
5. Progress of hearing loss in neurofibromatosis type 2: implications for future management.
Kontorinis G; Nichani J; Freeman SR; Rutherford SA; Mills S; King AT; Mawman D; Huson S; O'Driscoll M; Gareth Evans D; Lloyd SK
Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3143-50. PubMed ID: 25294053
[TBL] [Abstract][Full Text] [Related]
6. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
7. Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.
Holman MA; Schmitt WR; Carlson ML; Driscoll CL; Beatty CW; Link MJ
J Neurosurg Pediatr; 2013 Oct; 12(4):317-24. PubMed ID: 23909617
[TBL] [Abstract][Full Text] [Related]
8. Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.
Nowak A; Dziedzic T; Czernicki T; Kunert P; Morawski K; Niemczyk K; Marchel A
Neurol Neurochir Pol; 2015; 49(5):295-301. PubMed ID: 26377980
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation.
Zhao F; Wang B; Yang Z; Zhou Q; Li P; Wang X; Zhang J; Zhang J; Liu P
J Neurooncol; 2018 Jun; 138(2):417-424. PubMed ID: 29492767
[TBL] [Abstract][Full Text] [Related]
10. Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results.
Peyre M; Goutagny S; Bah A; Bernardeschi D; Larroque B; Sterkers O; Kalamarides M
Neurosurgery; 2013 Jun; 72(6):907-13; discussion 914; quiz 914. PubMed ID: 23407292
[TBL] [Abstract][Full Text] [Related]
11. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
[TBL] [Abstract][Full Text] [Related]
12. Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2.
Peng KA; Lorenz MB; Otto SR; Brackmann DE; Wilkinson EP
Laryngoscope; 2018 Sep; 128(9):2163-2169. PubMed ID: 29573425
[TBL] [Abstract][Full Text] [Related]
13. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
[TBL] [Abstract][Full Text] [Related]
14. Lesions of the internal auditory canal and cerebellopontine angle in an only hearing ear: is surgery ever advisable?
Driscoll CL; Jackler RK; Pitts LH; Brackmann DE
Am J Otol; 2000 Jul; 21(4):573-81. PubMed ID: 10912705
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
[TBL] [Abstract][Full Text] [Related]
16. Progression of hearing loss in neurofibromatosis type 2 according to genetic severity.
Emmanouil B; Houston R; May A; Ramsden JD; Hanemann CO; Halliday D; Parry A; Mackeith S
Laryngoscope; 2019 Apr; 129(4):974-980. PubMed ID: 30456886
[TBL] [Abstract][Full Text] [Related]
17. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
[TBL] [Abstract][Full Text] [Related]
18. Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.
Bonne N-; Aboukais R; Baroncini M; Hochart A; Leblond P; Broly F; Dubrulle F; Lejeune JP; Vincent C
Childs Nerv Syst; 2016 Dec; 32(12):2403-2413. PubMed ID: 27704245
[TBL] [Abstract][Full Text] [Related]
19. Hearing restoration in NF2 patients and patients with vestibular schwannoma in the only hearing ear: report of two cases.
Ozdek A; Bayır O; Dönmez T; Ozışık P; Sahin M; Tulgar M; Tatar EÇ; Korkmaz MH
Am J Otolaryngol; 2014; 35(4):538-41. PubMed ID: 24746329
[TBL] [Abstract][Full Text] [Related]
20. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]